Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin

被引：5
作者：
Wang, Bo [1 ]
Huang, Jie [2 ]
Chen, Li [3 ]
机构：
[1] Tianjin Med Univ Gen Hosp, Dept Paediat Surg, Tianjin, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Dept Resp & Crit Care Med, Tianjin, Peoples R China
[3] Ludwig Maximilian Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
来源：
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词：
medullary thyroid carcinoma (MTC); carcinoembryonic antigen (CEA); calcitonin (Ctn); perioperative management; follow-up; SERUM CALCITONIN; POSTOPERATIVE CALCITONIN; NEUROENDOCRINE TUMOR; SURGICAL-MANAGEMENT; RISK STRATIFICATION; CLINICAL CHALLENGES; ROUTINE MEASUREMENT; BASAL CALCITONIN; FREE SURVIVAL; CARCINOMA;
D O I：
10.3389/fendo.2024.1418657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Carcinoembryonic antigen (CEA) and calcitonin (Ctn) are pivotal biomarkers in the diagnosis and management of medullary thyroid carcinoma (MTC). However, their diagnostic reliability in perioperative period remains a topic of ongoing debate. This review synthesizes researches on perioperative fluctuations in CEA and Ctn levels, and evaluates the impact of their different combinations on MTC diagnosis, treatment decisions, and prognosis. Our findings highlight it is crucial to understand and interpret the various combinations of CEA and Ctn fluctuations within a clinical context. Furthermore, to reduce diagnostic errors and improve patient outcomes, we recommend follow-up diagnostic and treatment protocols designed to address the potential pitfalls associated with the use of these biomarkers.
引用
收藏
页数：11
相关论文
共 121 条
[1]   Medullary thyroid carcinoma presenting with an initial CEA elevation [J].
Abraham, Deepak ;
Delbridge, Leigh ;
Clifton-Bligh, Roderick ;
Clifton-Bligh, Phillip ;
Grodski, Simon ;
Robinson, Bruce G. ;
Messina, Marinella ;
Sidhu, Stan .
ANZ JOURNAL OF SURGERY, 2010, 80 (11) :831-833
[2]   A High Level of Carcinoembryonic Antigen as Initial Manifestation of Medullary Thyroid Carcinoma in a Patient With Subclinical Hyperthyroidism [J].
Akbulut, Sami ;
Sogutcu, Nilgun .
INTERNATIONAL SURGERY, 2011, 96 (03) :254-259
[3]   Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma [J].
Alapat, Daisy V. ;
Ain, Kenneth B. ;
Sloan, David A. ;
Monaghan, Kristin G. ;
Karabakhtsian, Rouzan G. .
ENDOCRINE, 2011, 39 (02) :148-152
[4]   Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome [J].
Alzumaili, Bayan ;
Xu, Bin ;
Spanheimer, Philip M. ;
Tuttle, R. Michael ;
Sherman, Eric ;
Katabi, Nora ;
Dogan, Snjezana ;
Ganly, Ian ;
Untch, Brian R. ;
Ghossein, Ronald A. .
MODERN PATHOLOGY, 2020, 33 (09) :1690-1701
[5]   Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma [J].
Bae, Soo Y. ;
Jung, Seung P. ;
Choe, Jun-Ho ;
Kim, Jee S. ;
Kim, Jung H. .
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2019, 35 (12) :772-777
[6]   Brain metastasis from calcitonin-negative medullary thyroid carcinoma [J].
Baptista, Patricia Ferreira ;
Martins Fonseca, Liliana Cecilia ;
Couto de Carvalho, Andre Filipe ;
Vieira da Silva, Sara Neves ;
Oliveira Freitas, Claudia Raquel .
ANNALES D ENDOCRINOLOGIE, 2022, 83 (04) :258-+
[7]   Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma [J].
Barbet, J ;
Campion, L ;
Kraeber-Bodéré, F ;
Chatal, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6077-6084
[8]   Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer [J].
Bardet, Stephane ;
Ciappuccini, Renaud ;
Lamartina, Livia ;
Leboulleux, Sophie .
EUROPEAN THYROID JOURNAL, 2022, 11 (02)
[9]   Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma [J].
Bockhorn, M ;
Frilling, A ;
Rewerk, S ;
Liedke, M ;
Dirsch, O ;
Schmid, KW ;
Broelsch, CE .
THYROID, 2004, 14 (06) :468-470
[10]   Management of treatment-related toxicities in advanced medullary thyroid cancer [J].
Brose, Marcia S. ;
Bible, Keith C. ;
Chow, Laura Q. M. ;
Gilbert, Jill ;
Grande, Carolyn ;
Worden, Francis ;
Haddad, Robert .
CANCER TREATMENT REVIEWS, 2018, 66 :64-73
12345678910